Skip to main content

Table 1 Characteristics of the Study Population

From: Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis

  Mortality
  Yes (n = 155) No (n = 732)
Characteristics Mean (SD) or % (Number) Mean (SD) or % (Number)
Social and demographic variables   
Age, yrs 35.97 (8.49) 31.35 (8.84)
Females 40.00% (62) 32.10% (235)
Karnofsky Score 71.74 (9.54) 75.17 (8.41)
Shillings* spent on food/person/day (quartiles)
   ≤ 250 28.37% (40) 23.14% (149)
   251-499 26.24% (37) 26.40% (170)
   500-750 26.24% (37) 27.17% (175)
   >750 19.15% (27) 23.29% (150)
TB related   
AFB Smear Result positive at baseline 96.75% (149) 94.12% (688)
AFB Culture positive at baseline 66.67% (44) 68.82% (287)
Laboratory Results   
Baseline Hemoglobin, g/dL 9.59 (1.59) 10.59 (1.82)
HIV- or Immune function related   
HIV infected 90.32% (140) 45.22% (331)
Baseline WHO HIV stage   
   3 85.96% (98) 93.48% (215)
   4 14.04% (16) 6.52% (15)
Baseline CD4 cell count/μL 238.15 (302.25) 564.04 (288.86)
Baseline CD3 cell count/μL 1086.23 (605.21) 1232.42 (501.09)
Baseline CD8 cell count/μL 785.61 (454.56) 601.85 (383.09)
CD4/CD8 Ratio 0.39 (0.71) 1.30 (0.90)
Log(10) viral load 5.11 (0.66) 4.38 (0.99)
   Q1 6.45% (10) 11.61% (85)
   Q2 14.19% (22) 9.97% (73)
   Q3 18.06% (28) 9.15% (67)
   Q4 34.84% (54) 5.60% (41)
Clinical signs and symptoms   
Diarrhea 9.45% (12) 10.12% (58)
Fatigue 71.65% (91) 66.32% (380)
Fever 55.12% (70) 64.22% (368)
Nausea/Vomiting 5.51% (7) 8.90% (51)
Skin Rash 20.47% (26) 8.90% (51)
Oral thrush 12.60% (16) 1.40% (8)
Weight loss 81.89% (104) 80.63% (462)
Extrapulmonary TB 1.57% (2) 2.44% (14)
Anthropometry   
BMI at enrolment, kg/m2 19.31 (3.04) 19.10 (2.64)
MUAC at enrolment, cm 23.25 (2.85) 23.25 (2.61)
  1. * 1000 Tanzanian Shillings ≈ 1 US Dollar at the time of the trial